February 7, 2024
(The Atlantic) – Already, seniors make up 26.6 percent of the people who have been prescribed these and other GLP-1 agonists, including Ozempic, since 2018, according to a report from Truveta, which draws data from a large network of health-care … Read More
February 7, 2024
February 6, 2024
(ABC News) – For cancer patients, the harsh side effects of powerful drugs have long been the trade-off for living longer. Now, patients and doctors are questioning whether all that suffering is necessary. They’ve ignited a movement to radically change … Read More
February 6, 2024
(New York Times) – If you’ve presented the same arm for every dose of a particular vaccine, you may want to reconsider. Alternating arms may produce a more powerful immune response, a new study suggests. The researchers studied responses to … Read More
February 6, 2024
(Axios) – Pharmacy retail chains staking their future on expanding the health care services they offer are running into a big problem: It’s getting harder to draw the next generation of pharmacists amid turmoil in the industry. Why it matters: … Read More
February 5, 2024
(Associated Press) – Money is pouring into the fledgling psychedelic medicine industry, with dozens of startup companies vying to be among the first to sell mind-expanding drugs for depression, addiction and other mental health conditions. While psychedelics are still illegal … Read More
February 5, 2024
(New York Magazine) – The drugs have been treated as an existential threat to the still-new body-positivity movement or a shortcutprimarily for the rich and already thin. Stories that have considered what the drugs could mean for the not-rich offer … Read More
February 2, 2024
(Axios) – Pandemic-era policies that made it easier for patients to receive opioid addiction treatment will continue permanently, the Biden administration announced this week. Why it matters: The changes mark the first time in 20 years the federal government has … Read More
February 2, 2024
(Wired) – One biotech startup, rBIO of Houston, is aiming to make insulin more affordable by producing a copycat version of the drug—known as a biosimilar. It’s not the only company developing biosimilar insulin, but it says it has invented … Read More
February 1, 2024
(Axios) – Surging demand for blockbuster anti-obesity drugs like Ozempic and Wegovy lifted Novo Nordisk’s market value past $500 billion on Wednesday, cementing the Danish drugmaker’s status as Europe’s biggest company by market cap. Why it matters: The company’s value … Read More
February 1, 2024
(STAT News) – New data released Thursday by the Centers for Disease Control and Prevention suggest that the most recent Covid-19 booster offers about 54% percent protection against infection with the virus. A study published in the CDC’s online journal … Read More
February 1, 2024
(Axios) – Aduhelm — the pricey Alzheimer’s drug that sparked congressional scrutiny of the Food and Drug Administration’s process for fast-tracking approvals as well as fears of Medicare insolvency — is coming off the market, drugmaker Biogen said Wednesday. Why it … Read More
February 1, 2024
(Axios) – New Medicare drug pricing negotiations, which kick into high gear Thursday, for the first time will allow the federal government to tie a medicine’s price to how well it works compared with similar treatments. Why it matters: Other … Read More
January 31, 2024
(Associated Press) – Several elected leaders in Oregon declared a state of emergency on Tuesday for downtown Portland over the public health and public safety crisis fueled by fentanyl. (Read More)
January 31, 2024
(Wall Street Journal) – 23andMe went public in 2021 and its valuation briefly topped $6 billion. Forbes anointed Anne Wojcicki, 23andMe’s chief executive and a Silicon Valley celebrity, as the “newest self-made billionaire.” Now Wojcicki’s self-made billions have vanished. 23andMe’s … Read More
January 31, 2024
(Axios) – As everyone in health care is trying to figure out which patients should get pricey new weight-loss drugs, a biotech company spun out of the Mayo Clinic is betting the genetics-based approach it’s pioneering may hold the answer. … Read More
January 31, 2024
(Wall Street Journal) – People who are suffering from severe pain but don’t want to risk addiction to an opioid are closer to a new option for treatment. Vertex Pharmaceuticals on Tuesday reported positive study results for its closely watched … Read More
January 30, 2024
(Axios) – There’s a notable gap in new federal rules requiring insurers to streamline decisions on whether they’ll cover treatments ordered by doctors: They don’t apply to drugs. Why it matters: Drugs account for a significant share of prior authorization … Read More
January 30, 2024
(New York Times) – As a result, consumers can end up nibbling an extra bite of a pot brownie or eating another gummy to feel more of an effect — and end up way too high when the drug finally … Read More
January 30, 2024
(NPR) – While it’s legal for doctors to prescribe ketamine, the FDA hasn’t approved it for mental health treatment, which means that individual practitioners develop their own treatment protocols. The result is wide variability among providers, with some favoring gradual, … Read More
January 30, 2024
(The Hill) – The Supreme Court will hear arguments on March 26 in a case that could limit the availability of the common abortion pill mifepristone. The justices will hear an appeal from the Biden administration and the maker of … Read More
January 29, 2024
(New York Times) – The Drug Enforcement Administration regarded Anthony L. Armour as an “outstanding” special agent on the front lines of the nation’s opioid epidemic. But in 2019, a routine drug test derailed his career. Months earlier, Mr. Armour … Read More
January 29, 2024
(New York Times) – Andrey Shevelyov would rather live on the street than take antipsychotic medication. Should it be his decision to make? As affordable apartments all but vanished in American cities, a whole tier of people with disabling mental … Read More
January 26, 2024
(Axios) – Women in low-income regions of the U.S. are experiencing significantly more cases and deaths from cervical cancer despite an overall decline of the disease, according to a new study in the International Journal of Cancer. Why it matters: … Read More
January 26, 2024
(Wall Street Journal) – The problem is that when you start taking a benzo, the brain reduces its natural output of GABA, which means that tapering off the medication can result in even worse symptoms of anxiety, along with extremely … Read More